| 注册
首页|期刊导航|中国医学创新|双联抗血小板治疗非轻型缺血性脑卒中的临床效果

双联抗血小板治疗非轻型缺血性脑卒中的临床效果

李娟 黄建锋 黄春 漆柳 叶金理

中国医学创新2024,Vol.21Issue(28):145-149,5.
中国医学创新2024,Vol.21Issue(28):145-149,5.DOI:10.3969/j.issn.1674-4985.2024.28.034

双联抗血小板治疗非轻型缺血性脑卒中的临床效果

Clinical Efficacy of Dual Antiplatelet Therapy for Non Mild Ischemic Stroke

李娟 1黄建锋 1黄春 1漆柳 2叶金理3

作者信息

  • 1. 萍乡市人民医院神经内科 江西 萍乡 337000
  • 2. 萍乡市人民医院重症医学科 江西 萍乡 337000
  • 3. 萍乡市人民医院急诊内科 江西 萍乡 337000
  • 折叠

摘要

Abstract

Objective:To explore the clinical effect of dual antiplatelet therapy in non-mild ischemic stroke.Method:A total of 91 patients with non-mild ischemic stroke treated in the Department of Neurology of Pingxiang People's Hospital from January 2021 to March 2023 were selected.A total of 7 patients dropped out of the study,and 84 patients were enrolled in the study.According to the random number table method,the patients were divided into control group(n=42)and study group(n=42).The control group was treated with Aspirin Enteric-coated Tablets,and the study group was treated with Aspirin combined with Clopidogrel,and the treatment was switched to Aspirin therapy 21 days later.The clinical effect,neurological function,adverse events and stroke recurrence before and after treatment were observed in two groups.Result:After three months of treatment,the clinical effective rate of the study group was 85.71%,which was significantly higher than that of the control group(66.67%),the difference was statistically significant(P<0.05).On the 7th,21th and three months day of treatment,the scores of national institutes of health stroke scale(NIHSS)in the study group were significantly lower than those in the control group,the differences were statistically significant(P<0.05).The stroke recurrence rate(2.38%)was significantly lower than that in the control group(14.29%),the difference was statistically significant(P<0.05).There was no significant difference in the incidence of adverse events between two groups(P>0.05).Conclusion:Dual antiplatelet therapy for non-mild ischemic stroke can effectively improve clinical symptoms,reduce stroke recurrence rate,restore neurological function without increasing the incidence of adverse events,and has good efficacy and safety.

关键词

缺血性脑卒中/阿司匹林肠溶片/安全性/氯吡格雷/神经功能

Key words

Ischemic stroke/Aspirin Enteric-coated Tablets/Safety/Clopidogrel/Neurological function

引用本文复制引用

李娟,黄建锋,黄春,漆柳,叶金理..双联抗血小板治疗非轻型缺血性脑卒中的临床效果[J].中国医学创新,2024,21(28):145-149,5.

基金项目

萍乡市科技计划项目(2022PY005) (2022PY005)

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文